Meilleure Health Wins Unanimous Minority Backing for Equity Transfer and 2026 Share Award Plan

Meilleure Health International Industry Group Limited ( (HK:2327) ) has issued an announcement.

Meilleure Health International Industry Group Limited secured shareholder approval at a special general meeting in Hong Kong on 21 April 2026 for a discloseable and connected transaction under an Equity Interest Transfer Agreement and for the adoption of its 2026 Share Award Scheme. The resolutions, voted on by way of poll among independent shareholders after major shareholder-related parties abstained, passed with 100% support of votes cast, clearing the way for the company to execute the equity transfer and implement the new incentive scheme, which is expected to influence its capital structure, governance alignment and employee incentives.

Independent shareholders controlled 1,488,260,875 shares, or about 36.40% of the company’s issued share capital excluding treasury shares, and there were no additional voting restrictions or stated opposition to the proposals. The unanimous poll results, verified by Tricor Investor Services Limited as scrutineer and with several board members in attendance, suggest solid backing from minority investors for Meilleure Health’s transaction plans and reward framework, potentially strengthening its flexibility for future corporate actions and talent retention in a competitive healthcare sector.

More about Meilleure Health International Industry Group Limited

Meilleure Health International Industry Group Limited is a Bermuda-incorporated company listed in Hong Kong. It operates in the health-related industry, overseeing a portfolio of businesses and investments aligned with its broader healthcare and wellness strategy in the Greater China market and beyond.

Average Trading Volume: 2,288,711

Technical Sentiment Signal: Buy

Current Market Cap: HK$1.15B

See more insights into 2327 stock on TipRanks’ Stock Analysis page.